Glutaredoxins concomitant with optimal ROS activate AMPK through S-glutathionylation to improve glucose metabolism in type 2 diabetes

Kelei Dong, Meiling Wu, Xiaomin Liu, Yanjie Huang, Dongyang Zhang, Yiting Wang, Liang-Jun Yan, Dongyun Shi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

AMPK dysregulation contributes to the onset and development of type 2 diabetes (T2DM). AMPK is known to be activated by reactive oxygen species (ROS) and antioxidant interference. However the mechanism by which redox state mediates such contradictory result remains largely unknown. Here we used streptozotocin-high fat diet (STZ-HFD) induced-type 2 diabetic rats and cells lines (L02 and HEK 293) to explore the mechanism of redox-mediated AMPK activation. We show glutaredoxins (Grxs) concomitant with optimal ROS act as an essential mediator for AMPK activation. ROS level results in different mechanisms for AMPK activation. Under low ROS microenvironment, Grxs-mediated S-glutathionylation on AMPK-α catalytic subunit activates AMPK to improve glucose transportation and degradation while inhibiting glycogen synthesis and keeping redox balance. While, under high ROS microenvironment, AMPK is activated by an AMP-dependent mechanism, however sustained high level ROS also causes loss of AMPK protein. This finding provides evidence for a new approach to diabetes treatment by individual doses of ROS or antioxidant calibrated against the actual redox level in vivo. Moreover, the novel function of Grxs in promoting glucose metabolism may provide new target for T2DM treatment.

Original languageEnglish
Pages (from-to)334-347
Number of pages14
JournalFree Radical Biology and Medicine
Volume101
DOIs
StatePublished - 1 Dec 2016

Fingerprint

Glutaredoxins
AMP-Activated Protein Kinases
Medical problems
Metabolism
Type 2 Diabetes Mellitus
Reactive Oxygen Species
Glucose
Oxidation-Reduction
Chemical activation
Antioxidants
HEK293 Cells
High Fat Diet
Adenosine Monophosphate
Nutrition
Streptozocin
Glycogen
Rats
Catalytic Domain
Fats
Cells

Keywords

  • AMPK
  • Glucose metabolism
  • Glutaredoxins
  • Glutathionylation
  • ROS
  • Type 2 diabetes

Cite this

Dong, Kelei ; Wu, Meiling ; Liu, Xiaomin ; Huang, Yanjie ; Zhang, Dongyang ; Wang, Yiting ; Yan, Liang-Jun ; Shi, Dongyun. / Glutaredoxins concomitant with optimal ROS activate AMPK through S-glutathionylation to improve glucose metabolism in type 2 diabetes. In: Free Radical Biology and Medicine. 2016 ; Vol. 101. pp. 334-347.
@article{45f52bf21fd94eca8b9ffc63716b06b2,
title = "Glutaredoxins concomitant with optimal ROS activate AMPK through S-glutathionylation to improve glucose metabolism in type 2 diabetes",
abstract = "AMPK dysregulation contributes to the onset and development of type 2 diabetes (T2DM). AMPK is known to be activated by reactive oxygen species (ROS) and antioxidant interference. However the mechanism by which redox state mediates such contradictory result remains largely unknown. Here we used streptozotocin-high fat diet (STZ-HFD) induced-type 2 diabetic rats and cells lines (L02 and HEK 293) to explore the mechanism of redox-mediated AMPK activation. We show glutaredoxins (Grxs) concomitant with optimal ROS act as an essential mediator for AMPK activation. ROS level results in different mechanisms for AMPK activation. Under low ROS microenvironment, Grxs-mediated S-glutathionylation on AMPK-α catalytic subunit activates AMPK to improve glucose transportation and degradation while inhibiting glycogen synthesis and keeping redox balance. While, under high ROS microenvironment, AMPK is activated by an AMP-dependent mechanism, however sustained high level ROS also causes loss of AMPK protein. This finding provides evidence for a new approach to diabetes treatment by individual doses of ROS or antioxidant calibrated against the actual redox level in vivo. Moreover, the novel function of Grxs in promoting glucose metabolism may provide new target for T2DM treatment.",
keywords = "AMPK, Glucose metabolism, Glutaredoxins, Glutathionylation, ROS, Type 2 diabetes",
author = "Kelei Dong and Meiling Wu and Xiaomin Liu and Yanjie Huang and Dongyang Zhang and Yiting Wang and Liang-Jun Yan and Dongyun Shi",
year = "2016",
month = "12",
day = "1",
doi = "10.1016/j.freeradbiomed.2016.10.007",
language = "English",
volume = "101",
pages = "334--347",
journal = "Free Radical Biology and Medicine",
issn = "0891-5849",
publisher = "Elsevier Inc.",

}

Glutaredoxins concomitant with optimal ROS activate AMPK through S-glutathionylation to improve glucose metabolism in type 2 diabetes. / Dong, Kelei; Wu, Meiling; Liu, Xiaomin; Huang, Yanjie; Zhang, Dongyang; Wang, Yiting; Yan, Liang-Jun; Shi, Dongyun.

In: Free Radical Biology and Medicine, Vol. 101, 01.12.2016, p. 334-347.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Glutaredoxins concomitant with optimal ROS activate AMPK through S-glutathionylation to improve glucose metabolism in type 2 diabetes

AU - Dong, Kelei

AU - Wu, Meiling

AU - Liu, Xiaomin

AU - Huang, Yanjie

AU - Zhang, Dongyang

AU - Wang, Yiting

AU - Yan, Liang-Jun

AU - Shi, Dongyun

PY - 2016/12/1

Y1 - 2016/12/1

N2 - AMPK dysregulation contributes to the onset and development of type 2 diabetes (T2DM). AMPK is known to be activated by reactive oxygen species (ROS) and antioxidant interference. However the mechanism by which redox state mediates such contradictory result remains largely unknown. Here we used streptozotocin-high fat diet (STZ-HFD) induced-type 2 diabetic rats and cells lines (L02 and HEK 293) to explore the mechanism of redox-mediated AMPK activation. We show glutaredoxins (Grxs) concomitant with optimal ROS act as an essential mediator for AMPK activation. ROS level results in different mechanisms for AMPK activation. Under low ROS microenvironment, Grxs-mediated S-glutathionylation on AMPK-α catalytic subunit activates AMPK to improve glucose transportation and degradation while inhibiting glycogen synthesis and keeping redox balance. While, under high ROS microenvironment, AMPK is activated by an AMP-dependent mechanism, however sustained high level ROS also causes loss of AMPK protein. This finding provides evidence for a new approach to diabetes treatment by individual doses of ROS or antioxidant calibrated against the actual redox level in vivo. Moreover, the novel function of Grxs in promoting glucose metabolism may provide new target for T2DM treatment.

AB - AMPK dysregulation contributes to the onset and development of type 2 diabetes (T2DM). AMPK is known to be activated by reactive oxygen species (ROS) and antioxidant interference. However the mechanism by which redox state mediates such contradictory result remains largely unknown. Here we used streptozotocin-high fat diet (STZ-HFD) induced-type 2 diabetic rats and cells lines (L02 and HEK 293) to explore the mechanism of redox-mediated AMPK activation. We show glutaredoxins (Grxs) concomitant with optimal ROS act as an essential mediator for AMPK activation. ROS level results in different mechanisms for AMPK activation. Under low ROS microenvironment, Grxs-mediated S-glutathionylation on AMPK-α catalytic subunit activates AMPK to improve glucose transportation and degradation while inhibiting glycogen synthesis and keeping redox balance. While, under high ROS microenvironment, AMPK is activated by an AMP-dependent mechanism, however sustained high level ROS also causes loss of AMPK protein. This finding provides evidence for a new approach to diabetes treatment by individual doses of ROS or antioxidant calibrated against the actual redox level in vivo. Moreover, the novel function of Grxs in promoting glucose metabolism may provide new target for T2DM treatment.

KW - AMPK

KW - Glucose metabolism

KW - Glutaredoxins

KW - Glutathionylation

KW - ROS

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84994663304&partnerID=8YFLogxK

U2 - 10.1016/j.freeradbiomed.2016.10.007

DO - 10.1016/j.freeradbiomed.2016.10.007

M3 - Article

C2 - 27743883

AN - SCOPUS:84994663304

VL - 101

SP - 334

EP - 347

JO - Free Radical Biology and Medicine

JF - Free Radical Biology and Medicine

SN - 0891-5849

ER -